PACIRA BIOSCIENCES IN

Pacira Appoints Frank D. Lee as Chief Executive Officer

21 Dec 2023 06:30:00 By Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications

10 Nov 2023 06:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November

07 Nov 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2023 Financial Results

02 Nov 2023 07:00:02 By Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023

26 Oct 2023 07:00:01 By Nasdaq GlobeNewswire

American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.

12 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors

10 Oct 2023 07:00:01 By Nasdaq GlobeNewswire

American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care

02 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Leadership Succession Plan

26 Sep 2023 15:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Second Quarter 2023 Financial Results

02 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023

26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference

31 May 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference

09 May 2023 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2023 Financial Results

03 May 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023

26 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner

20 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer

19 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources

03 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures

29 Mar 2023 07:00:00 By Nasdaq GlobeNewswire